|
Item 201 of Regulation S-K: Market Price of and Dividends on the Registrant’s Common Equity and Related Shareholder Matters |
Question or Interpretative Response Number[*] |
|
Equity Compensation Plan Information Table (Item 201(d)) |
|
|
Location of information regarding securities authorized for issuance under equity compensation plans in Item 12, Part III of Form 10-K.
Note: Part III information may be incorporated by reference into the Form 10-K from the company’s proxy statement for the annual shareholders meeting to be filed within 120 days. |
Q 4.01 |
|
Whether and how to include restricted stock subject to forfeiture. |
Q 4.02 |
|
Whether and how to include performance share awards and phantom shares. |
Q 4.03 |
|
Whether and how to include employee stock purchase plan shares. |
Q 4.04 |
|
Reporting weighted-average price information when some rights to purchase stock can be exercised for no consideration. |
Q 4.05 |
|
How to include equity compensation plan that has received Bankruptcy Court approval but not shareholder approval. |
I 4.01 |
|
How to include compensation plans that permit awards to be settled in either cash or stock, or cash only. |
I 4.02 |
|
How to treat foreign employee benefit plans that are similar to plans meeting the IRS 401(a) requirements (i.e., broad-based, compensatory and non-discriminatory). Exhibit filing requirements for these plans. |
I 4.03 |
|
How to treat stock appreciation rights exercisable for an amount of stock with a value equal to increase in value of common stock. |
I 4.04 |
|
Performance Graph (Item 201(e)) |
|
|
Plotting monthly or quarterly returns. |
Q 5.01 |
|
Weighting returns of component entities in a self-constructed peer or market capitalization index. |
Q 5.02
I 5.11 |
|
Excluding the issuer from a self-constructed peer or market capitalization index. |
Q 5.03 I 5.11 |
|
Correct choice of trading price for performance graphs including the issuer’s initial public offering. |
Q 5.04 I 5.09 I 5.10 |
|
Ability to exclude performance graph from 10-K report/requirement to include in annual report to shareholders. |
Q 5.05 Q 5.06 |
|
Including performance graph in proxy statement. |
Q 5.07 |
|
Disclosure of change in entities comprising self-constructed index. |
I 5.01 |
|
Change in listing exchange. |
I 5.02 |
|
Last trade data for a fiscal year. |
I 5.03 |
|
Performance Graph for a spin-off entity. |
I 5.04 |
|
Treatment of spin-off of a portion of a company’s business. |
I 5.05 |
|
Impact of merger or acquisition involving the reporting company. |
I 5.06 |
|
Peer group indexes for companies with several distinct lines of business. |
I 5.07 |
|
Change in company’s selection as its own peer group. |
I 5.08 |
|
Companies with a short fiscal year (e.g., following an IPO, resulting from a spin-off or emerging from bankruptcy). |
I 5.09 I 5.10 Q 5.01 |
|
Preparation of a “published industry or line-of-business index” by the reporting company and use of self-constructed indices. |
I 5.11 |
|
Item 403 of Regulation S-K: Security Ownership of Certain Beneficial Owners and Management |
|
|
Beneficial ownership of general partners and limited partners who will receive shares within 60 days following a public offering. |
I 1.01 |
|
Reports of “investment discretion” on 13-F reports vs. “beneficial ownership.” Reliance on Schedule 13D or Schedule 13G by issuers. |
I 1.02 |
|
Impact of IRS Section 409A tax consequences on determination of “beneficial ownership” under Rule 13d-3(d)(1). |
I 2.01 |
|
How to treat directors whose terms will not continue beyond next annual meeting. |
Q 2.01 |
|
Phantom stock units held in a nonqualified deferred compensation plan – right to settle in stock at election of holder vs. election of issuer. |
Q 2.02 |
|
Named executive officer who died since beginning of issuer’s last fiscal year. |
Q 2.03 |
|
Treatment of negative pledges (i.e., covenants by borrower to not transfer or encumber shares) as “pledges.” |
Q 2.04 Q 3.01 |
|
Item 404 of Regulation S-K: Transactions with Related Persons, Promoters and Certain Control Persons |
|
|
No need to restate disclosure reported under old rules for fiscal years ended prior to December 15, 2006. |
Q 1.01 |
|
Disclosure of 404(a) information pursuant to new rules in S-1 or Form 10 for fiscal years ended prior to December 15, 2006. |
Q. 1.02 |
|
Transactions with a value in excess of $120,000 with person who became a 5% shareholder after the beginning of the transaction. |
Q 2.01 |
|
Valuing unexercised, in-the-money stock options for determining whether $120,000 threshold is met. |
Q 2.02 |
|
Treatment of loans by banks to their employees for purposes of “comparable loans with persons not related to the lender” test. |
Q 2.03 |
|
Disclosure of related person transaction review, approval or ratification in absence of any disclosable transactions. |
Q 3.01 |
|
Treatment of in-laws and other extended relationships under “any immediate family member” test. |
I 2.01 |
|
Transactions with “immediate family members” of officers and directors of subsidiaries of the reporting company. |
I 2.01 |
|
Transactions with a value of less than $120,000 that are related to transactions with a value in excess of $120,000. |
I 2.03 |
|
Disqualifications from use of exclusion where rates or charges are based on competitive bids where bid awarded to related party who was not the lowest bidder or where the bidding process did not involve the use of formal procedures normally associated with competitive bidding procedures. |
I 2.04 I 2.05 |
|
Disclosure of contract with fund manager. |
I 2.06 |
|
Disclosure of salary paid to employee who is an immediate family member of an officer or director. |
I 2.07 |
|
Agreement with related person to repurchase company shares from related person’s estate with the proceeds of a life insurance policy. |
I 2.08 |
|
Disclosure of program to repurchase and resell homes of all employees affected by move of company’s headquarters. |
I 2.09 |
|
Reporting “nonaccrual, past due, restructured and potential problem loans” in proxy statements. |
I 2.10 |
|
Disclosure of split-fee arrangements where parent and subsidiary are both reporting companies and executives split duties between companies. |
I. 2.11 |
|
Item 407 of Regulation S-K: Corporate Governance |
|
|
Disclosure of compliance by non-listed issuer with independence definitions of a national securities exchange or the issuer’s own, more restrictive definitions. |
Q 1.01 |
|
Disclosure of nominating committee’s processes, policies or minimum director nominee qualifications must appear in its proxy statement. |
Q 3.01 |
|
Treatment of director not previously elected by shareholders under requirement to disclose information about persons or entities recommending nominee for director. |
Q 3.02 |
|
Period covered by Audit Committee Report. |
Q 4.01 |
|
Disclosure regarding compensation consultants with role in determining compensation of executives or directors. |
Q 5.01 |
|
No requirement for consents of compensation consultants. |
Q 5.02 |
|
Identifying the compensation committee members for the Compensation Committee Report. |
Q 5.03 |
|
Calculating director’s attendance at meetings of the board of directors without including actions by written consent. |
I 2.01 |
|
Caption for “Compensation Committee Interlocks and Insider Participation” not required where no reportable transactions or relationships. |
I 5.01 |
|
Disclosure obligations where multiple board committees have responsibility for different components of compensation (e.g., a stock option committee). |
I 5.02 |